all talking about demand. no demand. no interest. no good info. no good promoter. how to attract traders. only full of rubbish cut and paste vaccine articles. like this how to attract traders. correct?
kanger too much rubbish useless vaccine articles. dampen the share price. traders not coming to trade . vol drop. shark how to make money like this. correct?
no short term demand. how to push the price higher.all wait ling term but anxious about short term. thats why keep posting rubbish vaccines article non stop to attract buyers. correct?
Currently, four Covid-19 vaccines from three Chinese firms are at an advanced stage: Sinopharm has two vaccines in development; private US-listed biotech firm Sinovac has developed a shot called CoronaVac; and CanSino Biologics also has a candidate. Unlike the Pfizer and Moderna vaccines, China’s candidates don’t require ultra-cold storage, making them especially useful to developing countries.
The Sinopharm vaccines have been tested on 60,000 volunteers across Argentina, Bahrain, Egypt, Indonesia, Jordan, Morocco, Peru, Russia, Saudia Arabia, and the United Arab Emirates as part of Phase 3 trials. Sinovac’s CoronaVac has been tested in Brazil, Chile, Turkey, and Indonesia, among others. Neither company has released information on efficacy.
Currently, four Covid-19 vaccines from three Chinese firms are at an advanced stage: Sinopharm has two vaccines in development.
The Sinopharm vaccines have been tested on 60,000 volunteers across Argentina, Bahrain, Egypt, Indonesia, Jordan, Morocco, Peru, Russia, Saudia Arabia, and the United Arab Emirates as part of Phase 3 trials.
Fair price is 0.16 I think. That's why you see no one wants to buy 0.17 even. Real investors wont let this go by if there is a gain to be made - even if there is a certain length of waiting time. Unless you see a spurt in price, there is not much purpose singing praises
Kanger International Berhad ("Kanger" or "Company") and its subsidiary companies ("Group") - Letter from National Institutes of Biotechnology Malaysia, an Agency under Ministry of Science, Technology and Innovation Malaysia on Distribution of Sinopharm's Covid-19 Vaccines KANGER INTERNATIONAL BERHAD
Letter from National Institutes of Biotechnology Malaysia, an Agency under Ministry of Science, Technology and Innovation Malaysia on Distribution of Sinopharm's Covid-19 Vaccines Reference is made to Kanger’s announcement on 29 September 2020 (ref no. GA1-29092020-00043) whereby the Group had entered into a three-year collaboration agreement with Sinopharm Group Hunan Changde Medical Co Ltd for the distribution of Covid-19 vaccines and medical equipment in Malaysia which are developed by China National Pharmaceutical Group Corporation (“Sinopharm”).
The Board of Directors of Kanger is pleased to announce that National Institutes of Biotechnology Malaysia (“NIBM”), an agency under the Ministry of Science, Technology and Innovation Malaysia has issued a letter which states that NIBM has no objections for Kanger to communicate with the relevant stakeholders at Sinopharm to purchase Covid-19 vaccines for private sector use in Malaysia.
Please refer to the full announcement as attached.
Pp today listIng... kanger good news will announce soon... if kanger good news announce early ,company need push down price for pp...so there won't announced anny good news b4 pp...pp today complete, kanger good news coming soon
kanger is the least prefer vaccine ctr. thats why vaccine news no effect on the share price. if yes why still want to flood the forum with vaccine articles. no common sense. still insist will have effect on the share price. correct?
still no common sense how to use forum effectively? when forum flooded with rubbish and useless vaccine articles. more real investors will not able to access the real information about what kanger are all about kanger is about bamboo business usd100 billion market and spent over rm100mil into building bamboo latest plant where the whole kanger is all about. how much kanger spent on vaccine. unable to access any figure at all and you all keep promoting kanger as vaccine ctr and keep flooding the forum with rubbish vaccine informations. Want vaccine info go MOH website lah. see when MOH approve china vaccine lah. thats the most important news lah. not tons of rubbish oversea news. what for lah. kanger is vaccine one stop information ctr kah. correct?
@2323 if kanger good news announce early ,company need push down price for pp...so there won't announced anny good news b4 pp...pp today complete, kanger good news coming soon
Not logical. If you have a share price driven by good news, say twice the PP, then the PP recipient will be more than happy to accept because of the instant profitability. Isnt it?
What I suspect is happening is the company directors are mopping up at 0.17 so that market price will not be lower than PP. If it is, then why should companies invest in the PP, might as well pick cheap from the market
FYI. sinopham vaccine got approved today. If the kanger and sinopham vaccine agreement valid. Very soon it will fly. This is first China vaccine got approved.
Bowman..... pp need find buyer buy...director or boss kanger all cant buy pp...., why there no want goreng to 0.50 ,1.00 then pp will higher.... yes there can ,but who want buy... all buyer just want buy cheap price...who want buy expensive price...so there will discuss with buyer first... ,go and learn pp then you will understand...bowman jom...we go minum kopi o ....
Testing vaccines need thousands of volunteers to take the test. Sinopharm tested 60,000 people. Malaysia is trying to test 3000 people as part of study group.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
UlarSawa
35,552 posts
Posted by UlarSawa > 2020-12-11 09:39 | Report Abuse
all talking about demand. no demand. no interest. no good info. no good promoter. how to attract traders. only full of rubbish cut and paste vaccine articles. like this how to attract traders. correct?